Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis. Issue 3 (2nd March 2022) - Hassan-Zahraee, Mina; Ye, Zhan; Xi, Li; Baniecki, Mary Lynn; Li, Xingpeng; Hyde, Craig L; Zhang, Jenny; Raha, Nancy; Karlsson, Fridrik; Quan, Jie; Ziemek, Daniel; Neelakantan, Srividya; et al.